| MESOBLAST LTD. |
| Australien |
| Gesundheit |
| AU000000MSB8 / A0DNPW |
| LWB (Frankfurt) |
| FRA:LWB, ETR:LWB, LWB:GR |
| - |
| https://www.mesoblast.com.. |
|
Mesoblast Limited is a biotechnology company specializing in the development of allogeneic, or off-the-shelf, cellular medicines intended for the treatment of severe and life-threatening inflammatory conditions. Leveraging a proprietary technology pl..
>Volltext.. |
| 2123.91 Mio. EUR |
| 2144.9 Mio. EUR |
| 105.11 Mio. EUR |
| -37.83 Mio. EUR |
| -51.22 Mio. EUR |
| -0.04 EUR |
| 109.5 Mio. EUR |
| 88.5 Mio. EUR |
| -56.77 Mio. EUR |
| 1.27 |
| 589.78% |
| 42.75% |
| - |
| - |
| - |
| - |
| MESOBLAST |
| 08.09.26 |
|